Log in to save to my catalogue

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed2c93a7dc37498fbec7637b1bcc0b99

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

About this item

Full title

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2022-07, Vol.20 (1), p.320-18, Article 320

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Nanovaccines have shown the promising potential in controlling and eradicating the threat of infectious diseases worldwide. There has been a great need in developing a versatile strategy to conveniently construct diverse types of nanovaccines and induce potent immune responses. To that end, it is critical for obtaining a potent self-adjuvant platfo...

Alternative Titles

Full title

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ed2c93a7dc37498fbec7637b1bcc0b99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed2c93a7dc37498fbec7637b1bcc0b99

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-022-01533-3

How to access this item